Complex clinical scenarios with the use of direct oral anticoagulants in patients with atrial fibrillation: a multidisciplinary expert advisory board

B.A. Mulder, J. ten Berg, H. ten Cate, N. van Es, M.E.W. Hemels, L.J. Kappelle, H.B.B. Bakker, G.J. de Borst, D.J. Drenth, G.J. Geersing, M. Rienstra

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)504-513
Number of pages10
JournalNetherlands Heart Journal
Volume28
Issue number10
DOIs
Publication statusPublished - 1 Oct 2020

Keywords

  • anticoagulation
  • antithrombotic therapy
  • atrial fibrillation
  • co-morbidities
  • direct oral anticoagulant
  • european-society
  • guidelines
  • management
  • percutaneous coronary intervention
  • prevention
  • rivaroxaban
  • stroke
  • stroke prevention
  • thromboembolism
  • warfarin
  • RIVAROXABAN
  • GUIDELINES
  • Anticoagulation
  • STROKE
  • Stroke prevention
  • ANTITHROMBOTIC THERAPY
  • THROMBOEMBOLISM
  • MANAGEMENT
  • Direct oral anticoagulant
  • Atrial fibrillation
  • PREVENTION
  • EUROPEAN-SOCIETY
  • PERCUTANEOUS CORONARY INTERVENTION
  • Co-morbidities
  • WARFARIN

Cite this